Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$441M |
| 2 |
Broadcom
AVGO
|
+$328M |
| 3 |
Pfizer
PFE
|
+$292M |
| 4 |
Tesla
TSLA
|
+$252M |
| 5 |
IBM
IBM
|
+$209M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares National Muni Bond ETF
MUB
|
+$295M |
| 2 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$138M |
| 3 |
General Mills
GIS
|
+$131M |
| 4 |
Chevron
CVX
|
+$116M |
| 5 |
PPG Industries
PPG
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.91% |
| 2 | Financials | 13.22% |
| 3 | Healthcare | 13.19% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
4D Molecular Therapeutics
FDMT
$532M
| $1.7M | ﹤0.01% |
210,942
+34,841
| +20% | +$316K |
|
|
VLD
2627
DELISTED
Velo3D, Inc.
VLD
| $1.69M | ﹤0.01% |
12,238
+1,231
| +11% | +$160K |
|
2628
Roivant Sciences
ROIV
$24.5B
| $1.68M | ﹤0.01% |
521,631
-191,580
| -27% | -$742K |
|
2629
Weibo
WB
$2B
| $1.67M | ﹤0.01% |
97,798
+868
| +0.9% | +$16.8K |
|
2630
Invesco Dividend Achievers ETF
PFM
$791M
| $1.66M | ﹤0.01% |
51,427
+11,218
| +28% | +$399K |
|
2631
BioXcel Therapeutics
BTAI
$24.9M
| $1.66M | ﹤0.01% |
8,781
+960
| +12% | +$223K |
|
2632
The Joint Corp
JYNT
$118M
| $1.65M | ﹤0.01% |
105,017
+4,415
| +4% | +$78.5K |
|
|
ZIMV
2633
DELISTED
ZimVie
ZIMV
| $1.65M | ﹤0.01% |
167,075
+490
| +0.3% | +$7.91K |
|
|
ROCC
2634
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $1.65M | ﹤0.01% |
52,359
-3,251
| -6% | -$114K |
|
|
JOYY
2635
JOYY Inc
JOYY
$3.71B
| $1.64M | ﹤0.01% |
63,128
+558
| +0.9% | +$15.3K |
|
2636
Alphatec Holdings
ATEC
$1.46B
| $1.63M | ﹤0.01% |
186,567
+4,647
| +3% | +$36.8K |
|
|
EXPR
2637
DELISTED
Express, Inc.
EXPR
| $1.63M | ﹤0.01% |
74,733
+2,911
| +4% | +$99.4K |
|
2638
Lindblad Expeditions
LIND
$1.94B
| $1.63M | ﹤0.01% |
240,909
+15,841
| +7% | +$138K |
|
2639
Dole
DOLE
$1.35B
| $1.63M | ﹤0.01% |
222,863
+95,601
| +75% | +$850K |
|
|
ZYXI
2640
DELISTED
Zynex
ZYXI
| $1.61M | ﹤0.01% |
177,060
+7,229
| +4% | +$63.2K |
|
2641
CRA International
CRAI
$1.16B
| $1.6M | ﹤0.01% |
18,071
-285
| -2% | -$26.2K |
|
|
LICY
2642
DELISTED
Li-Cycle Holdings Corp.
LICY
| $1.6M | ﹤0.01% |
37,582
+992
| +3% | +$53.9K |
|
2643
Bioventus
BVS
$892M
| $1.59M | ﹤0.01% |
227,809
+53,959
| +31% | +$422K |
|
|
IGMS
2644
DELISTED
IGM Biosciences
IGMS
| $1.59M | ﹤0.01% |
70,096
+4,811
| +7% | +$97.1K |
|
2645
Thryv Holdings
THRY
$180M
| $1.59M | ﹤0.01% |
69,804
+7,119
| +11% | +$177K |
|
2646
Universal Logistics Holdings
ULH
$353M
| $1.59M | ﹤0.01% |
50,250
-2,867
| -5% | -$94.7K |
|
2647
Lexicon Pharmaceuticals
LXRX
$1.03B
| $1.59M | ﹤0.01% |
662,478
+227,914
| +52% | +$631K |
|
2648
Dream Finders Homes
DFH
$1.16B
| $1.58M | ﹤0.01% |
149,420
+14,485
| +11% | +$175K |
|
2649
Precigen
PGEN
$2.24B
| $1.58M | ﹤0.01% |
746,525
+77,701
| +12% | +$164K |
|
|
LGTY
2650
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $1.57M | ﹤0.01% |
102,712
+20,135
| +24% | +$342K |
|
Similar funds
Charles Schwab's Q3 2022 Portfolio in Review
As of Q3 2022, Charles Schwab held 3,614 positions worth $279B, down 2.9% from $287B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab deployed $8.77B of net new capital in Q3 2022, opening 79 new positions and adding to 2,461 existing holdings. Its largest new stake was JPMorgan Ultra-Short Income ETF: 2,974,316 shares worth $149M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares National Muni Bond ETF, an estimated $295M trimmed.
- Charles Schwab's largest Q3 2022 buy was JPMorgan Ultra-Short Income ETF: 2,974,316 shares worth $149M.
- Charles Schwab added most to Verizon in Q3 2022, an estimated $441M increase.
- Charles Schwab's biggest Q3 2022 reduction was iShares National Muni Bond ETF, cutting an estimated $295M.
- Charles Schwab fully exited American Campus Communities, Inc. in Q3 2022, selling an estimated $91.4M.
- Charles Schwab's ten largest holdings make up 17% of its $279B portfolio in Q3 2022.
- Charles Schwab opened 79 new positions and closed 105 in Q3 2022.
- Charles Schwab's portfolio value fell 2.9% quarter-over-quarter to $279B.
Based on Charles Schwab's 13F filing for Q3 2022, filed 14 Nov 2022.